Michael Okunewitch
Stock Analyst
(n/a)
# 4,633
Out of 4,641 analysts
18
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Okunewitch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCGN Ocugen | Initiates: Buy | $4 | $0.91 | +339.51% | 1 | Oct 15, 2024 | |
| FBLG FibroBiologics | Initiates: Buy | $12 | $2.83 | +324.03% | 1 | Sep 24, 2024 | |
| LGVN Longeveron | Maintains: Buy | $15 → $6 | $2.22 | +170.27% | 2 | Aug 27, 2024 | |
| CMMB Chemomab Therapeutics | Initiates: Buy | $4 | $1.55 | +158.06% | 1 | May 13, 2024 | |
| LEXX Lexaria Bioscience | Maintains: Buy | $3 → $12 | $2.70 | +344.44% | 2 | Mar 5, 2024 | |
| ACRV Acrivon Therapeutics | Initiates: Buy | $24 | $8.06 | +197.77% | 1 | Oct 5, 2023 | |
| ANEB Anebulo Pharmaceuticals | Initiates: Buy | $6 | $1.89 | +217.46% | 1 | Sep 21, 2023 | |
| KPRX Kiora Pharmaceuticals | Maintains: Buy | $108 → $18 | $3.52 | +411.36% | 3 | Aug 9, 2023 | |
| ALZN Alzamend Neuro | Initiates: Buy | $225 | $1.62 | +13,788.89% | 1 | Apr 12, 2023 | |
| MDWD MediWound | Initiates: Buy | $25 | $16.79 | +48.90% | 1 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $1.60 | +275.00% | 1 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $0.51 | +684.31% | 1 | Mar 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $1.21 | +1,966.12% | 1 | Nov 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $0.36 | +1,020.13% | 1 | Nov 30, 2021 |
Ocugen
Oct 15, 2024
Initiates: Buy
Price Target: $4
Current: $0.91
Upside: +339.51%
FibroBiologics
Sep 24, 2024
Initiates: Buy
Price Target: $12
Current: $2.83
Upside: +324.03%
Longeveron
Aug 27, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $2.22
Upside: +170.27%
Chemomab Therapeutics
May 13, 2024
Initiates: Buy
Price Target: $4
Current: $1.55
Upside: +158.06%
Lexaria Bioscience
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $12
Current: $2.70
Upside: +344.44%
Acrivon Therapeutics
Oct 5, 2023
Initiates: Buy
Price Target: $24
Current: $8.06
Upside: +197.77%
Anebulo Pharmaceuticals
Sep 21, 2023
Initiates: Buy
Price Target: $6
Current: $1.89
Upside: +217.46%
Kiora Pharmaceuticals
Aug 9, 2023
Maintains: Buy
Price Target: $108 → $18
Current: $3.52
Upside: +411.36%
Alzamend Neuro
Apr 12, 2023
Initiates: Buy
Price Target: $225
Current: $1.62
Upside: +13,788.89%
MediWound
Dec 22, 2022
Initiates: Buy
Price Target: $25
Current: $16.79
Upside: +48.90%
Sep 28, 2022
Initiates: Buy
Price Target: $6
Current: $1.60
Upside: +275.00%
Mar 24, 2022
Initiates: Buy
Price Target: $4
Current: $0.51
Upside: +684.31%
Nov 30, 2021
Initiates: Buy
Price Target: $25
Current: $1.21
Upside: +1,966.12%
Nov 30, 2021
Initiates: Buy
Price Target: $4
Current: $0.36
Upside: +1,020.13%